Cliff Asness's IDYA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 42,163 shares of IDEAYA Biosciences, Inc. (IDYA) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in IDYA, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 45,951 shares. Largest reduction occurred in Q1 2026, reducing 26,014 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's IDEAYA Biosciences (IDYA) Holding Value Over Time
Track share changes against reported price movement
Quarterly IDEAYA Biosciences (IDYA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -26,014 | Reduce 38.16% | 42,163 | $33.32 |
| Q4 2025 | +45,951 | Add 206.74% | 68,177 | $34.57 |
| Q3 2025 | +1,867 | Add 9.17% | 22,226 | $27.21 |
| Q2 2025 | +20,359 | New Buy | 20,359 | $21.02 |
| Q1 2025 | -13,763 | Sold Out | 0 | $0.00 |
| Q4 2024 | -1,989 | Reduce 12.63% | 13,763 | $25.70 |
| Q3 2024 | +120 | Add 0.77% | 15,752 | $31.68 |
| Q2 2024 | -1,264 | Reduce 7.48% | 15,632 | $35.11 |
| Q1 2024 | +1,017 | Add 6.40% | 16,896 | $43.88 |
| Q4 2023 | -1,205 | Reduce 7.05% | 15,879 | $35.58 |
| Q3 2023 | +4,575 | Add 36.57% | 17,084 | $26.98 |
| Q2 2023 | +12,509 | New Buy | 12,509 | $23.50 |
| Q1 2022 | -12,336 | Sold Out | 0 | $0.00 |
| Q4 2021 | +12,336 | New Buy | 12,336 | $23.67 |
| Q3 2021 | -24,853 | Sold Out | 0 | $0.00 |
| Q2 2021 | -6,213 | Reduce 20.00% | 24,853 | $21.00 |
| Q1 2021 | -7,893 | Reduce 20.26% | 31,066 | $23.50 |
| Q4 2020 | +38,959 | New Buy | 38,959 | $13.99 |
Cliff Asness's IDEAYA Biosciences Investment FAQs
Cliff Asness first purchased IDEAYA Biosciences, Inc. (IDYA) in Q4 2020, acquiring 38,959 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held IDEAYA Biosciences, Inc. (IDYA) for 18 quarters since Q4 2020.
Cliff Asness's largest addition to IDEAYA Biosciences, Inc. (IDYA) was in Q4 2025, adding 68,177 shares worth $2.36 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 42,163 shares of IDEAYA Biosciences, Inc. (IDYA), valued at approximately $1.4 M.
As of the Q1 2026 filing, IDEAYA Biosciences, Inc. (IDYA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in IDEAYA Biosciences, Inc. (IDYA) was 68,177 shares, as reported at the end of Q4 2025.